Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|December 24, 2021
Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney DiseaseXinyu Wang, Jiaqing Xiang, Guixiao Huang, et al.
Cell Reports|April 8, 2023
Sp1-like protein KLF13 acts as a negative feedback regulator of TGF-β signaling and fibrosisShu Yang, Jiaqing Xiang, Chuanrui Ma, et al.
Cell Reports|February 20, 2025
HSPA8 dampens SCAP/INSIG split and SREBP activation by reducing PKR-mediated INSIG phosphorylationGuangyan Yang, Chuanrui Ma, Yuanli Chen, et al.
Pharmacological Research|February 5, 2020
Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathwayShu Yang, Chuanrui Ma, Han Wu, et al.
Diabetologia|December 16, 2021
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathwayShu Yang, Guangyan Yang, Han Wu, et al.
Communications Biology|November 27, 2025
Lactate orchestrates the TGFβ pathway and ferroptosis nexus in organ fibrosis via USP2 lactylationJiaqing Xiang, Guangyan Yang, LiXing Li, et al.
British Journal of Pharmacology|October 29, 2021
Calycosin ameliorates atherosclerosis by enhancing autophagy via regulating the interaction between KLF2 and MLKL in apolipoprotein E gene-deleted miceChuanrui Ma, Han Wu, Guangyan Yang, et al.
Horticulture Research|November 29, 2023
Telomere-to-telomere pear (<i>Pyrus pyrifolia</i>) reference genome reveals segmental and whole genome duplication driving genome evolutionManyi Sun, Chenjie Yao, Qun Shu, et al.
Frontiers in Endocrinology|August 8, 2022
REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney DiseaseXinyu Wang, Han Wu, Guangyan Yang, et al.
Frontiers in Pharmacology|December 13, 2021
Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and MacrophagesChuanrui Ma, Jiaqing Xiang, Guixiao Huang, et al.
Pageof 5